Title21 Health Solutions acquires MyCellHub to expand digital capabilities
Strategic acquisition accelerates Title21’s mission to deliver comprehensive, compliant, and integrated digital solutions for regulated healthcare and life sciences organizations across the cell and gene therapy ecosystem
14 Jan 2026
Title21 Health Solutions, a leading provider of enterprise quality management systems and cell and gene therapy orchestration platforms, has acquired MyCellHub and its advanced manufacturing execution system (MES) platform, expanding Title21’s ability to connect the advanced therapies ecosystem through cutting-edge digital solutions.
Through the acquisition of MyCellHub, Title21 strengthens its position to serve as the data bridge connecting entities across the advanced therapies ecosystem, driving data sharing and transparency, accelerating research and therapy development, and bringing hope to patients and families through the medicine of tomorrow.
The newly acquired MES will expand Title21’s solution portfolio, which includes Quality Management Systems (QMS), cell and gene therapy orchestration platforms, and advanced analytics offerings – all designed to meet the unique needs of providers of advanced therapy medicinal products (ATMPs).
Adding a MES platform to its solution portfolio, Title21 is now in a unique position to become a single-source provider for standard of care (hematopoietic cell transplant), advanced biotherapy manufacturing, integrated analytics, and quality management systems.
The MES technology is specifically designed to meet the stringent requirements of the healthcare, biotech, and cell therapy sectors by delivering real-time production monitoring, digital batch record management, and embedded quality management within manufacturing operations.
“This strategic addition to our expanding product portfolio, positions Title21 as the leader in arm-to-arm workflow, documentation, and compliance solutions for the developers, manufacturers, and clinical providers of life saving biotherapies. It also expands our geographic coverage in North America and Australia to include Europe. We welcome the Belgium-based MyCellHub team to Title21 and look forward to adding them to our committed group of professionals advancing healthcare IT in this important industry,” said Tony Pare, CEO of Title21.